Bardin T, Richette P. Definition of hyperuricemia and gouty conditions. Curr Opin Rheumatol 2014; 26: 186-91.
Sluijs I, Beulens JW, van der A DL, Spijkerman AM, Schulze MB, van der Schouw YT. Plasma uric acid is associated with increased risk of type 2 diabetes independent of diet and metabolic risk factors. J Nutr 2013; 143: 80-5.
Filiopoulos V, Hadjiyannakos D, Vlassopoulos D. New insights into uric acid effects on the progression and prognosis of chronic kidney disease. Ren Fail 2012; 34: 510-20.
de Oliveira EP, Burini RC. High plasma uric acid concentration: causes and consequences. Diabetol Metab Syndr 2012; 4: 12.
Puddu P, Puddu GM, Cravero E, Vizioli L, Muscari A. Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications. J Cardiol 2012; 59: 235-42.
Kawano Y. Uric acid and blood pressure. Circ J 2011; 75: 2755-6.
Gertler MM, Garn SM, Levine SA. Serum uric acid in relation to age and physique in health and in coronary heart disease. Ann Intern Med 1951; 34:1421-31.
Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008; 359: 1811-21.
Chang CC, Wu CH, Liu LK, Chou RH, Kuo CS, Huang PH, et al. Association between serum uric acid and cardiovascular risk in nonhypertensive and nondiabetic individuals: the Taiwan I-Lan Longitudinal Aging Study. Sci Rep 2018; 8: 5234.
Yeh ET. CRP as a mediator of disease. Circulation 2004; 109(21 Suppl 1):II11-4.
Kim KH. The role of chronic infection and inflammation in Korean patients with coronary artery disease. Korean Circ J 2000; 30: 1107-16.
Wasilewska A, Tenderenda E, Taranta-Janusz K, Tobolczyk J, Stypułkowska J. Markers of systemic inflammation in children with hyperuricemia. Acta Paediatr 2012; 101: 497-500.
Yang T, Ding X, Wang YL, Zeng C, Wei J, Li H, et al. Association between high-sensitivity C-reactive protein and hyperuricemia. Rheumatol Int 2016;36: 561-6.
Ho WJ, Tsai WP, Yu KH, Tsay PK, Wang CL, Hsu TS, et al. Association between endothelial dysfunction and hyperuricaemia. Rheumatology (Oxford) 2010; 49: 1929-34.
International Physical Activity Questionnaire Research Committee. Guideline for data processing and analysis of the International Physical Activity Questionnaire [Internet]. International Physical Activity Questionnaire;2005 [cited 2014 Aug 24].
Kawamoto R, Tabara Y, Kohara K, Miki T, Kusunoki T, Takayama S, et al. Usefulness of combining serum uric acid and high-sensitivity C-reactive protein for risk stratification of patients with metabolic syndrome in community-dwelling women. Endocrine 2013; 44: 132-9.
Sah SK, Khatiwada S, Pandey S, Kc R, Das BK, Baral N, et al. Association of high-sensitivity C-reactive protein and uric acid with the metabolic syndrome components. Springerplus 2016; 5: 269.
Choi NY, Koh HM, Lee JH. Association of serum uric acid level with risk factors of cardiovascular disease and coronary artery calcium score. Korean J Fam Pract 2016; 6; 215-20.
Kang DH. Does hyperuricemia play a causative role in the development and/or aggravation of renal, cardiovascular and metabolic disease? Korean J Med 2011; 80: 524-8.
Muiesan ML, Agabiti-Rosei C, Paini A, Salvetti M. Uric acid and cardiovascular disease: an update. Eur Cardiol 2016; 11: 4-59.
Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med 1999; 340:115-26.
Yasojima K, Schwab C, McGeer EG, McGeer PL. Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol 2001; 158: 1039-51.
Ouchi N, Kihara S, Funahashi T, Nakamura T, Nishida M, Kumada M, et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 2003; 107: 671-4.
Yasojima K, Schwab C, McGeer EG, McGeer PL. Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease. Brain Res 2000; 887: 80-9.